This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Clinical application of a 3D ultrasound-guided prostate biopsy system - Abstract
June 2, 2011
Characterization of bone metastases from rapid autopsies of prostate cancer patients - Abstract
June 2, 2011
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer - Abstract
June 2, 2011
Bone metastasis in prostate cancer: Emerging therapeutic strategies - Abstract
June 2, 2011
Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration - Abstract
June 2, 2011
Knowledge of symptoms and diagnostic possibilities of cancer diseases - Abstract
June 1, 2011
Behind closed doors II: Systematic analysis of prostate cancer patients' primary treatment consultations with radiation oncologists and predictors of satisfaction with communication - Abstract
June 1, 2011
Retargeting of T cells to prostate stem cell antigen expressing tumor cells: Comparison of different antibody formats - Abstract
June 1, 2011
Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer - Abstract
June 1, 2011
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models - Abstract
June 1, 2011
Immunotherapy in castration-resistant prostate cancer: Integrating sipuleucel-T into our current treatment paradigm - Abstract
June 1, 2011
Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients - Abstract
June 1, 2011
The role of abiraterone acetate in the management of prostate cancer: A critical analysis of the literature - Abstract
June 1, 2011
High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A Phase II trial - Abstract
June 1, 2011
Dealing with a troublesome body: A qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy - Abstract
June 1, 2011
Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study - Abstract
June 1, 2011
Editor's Commentary - Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: Improved outcomes with stringent enrollment criteria
June 1, 2011
Hospital & Healthsystem Association of Pennsylvania (HAP) to host CUSP/CAUTI conference
June 1, 2011
UroToday Slide Library - History of patupilone: From bench to clinic
June 1, 2011
UroToday Slide Library - Hormone-refractory prostate cancer
June 1, 2011
Page 1390 of 1435
Start
Prev
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
